Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02282787
Other study ID # E-14-1291
Secondary ID
Status Active, not recruiting
Phase Phase 3
First received October 31, 2014
Last updated March 30, 2015
Start date January 2014
Est. completion date May 2015

Study information

Verified date March 2015
Source King Saud University
Contact n/a
Is FDA regulated No
Health authority Saudi Arabia: Ministry for Higher Education
Study type Interventional

Clinical Trial Summary

During LA in retinal surgery there is some problem as regard the lack of anaesthesia duration and unexpected globe movement .so many adjuvant was added to LA to overcome this disadvantages of LA such as clonidine and fentanyl .

The investigators hypothesis is adding dexmedetomidine to pribulbal blocking LA will prolong anaesthesia duration and improve globe akinesia and decrease intraoperative supplementation of LA.There are Many studies had described the effects of dexmedetomidine on peripheral nerve blocks, spinal but up to date no knowledge is available on the impact of dexmedetomidine adjuvant to local anaesthetic in ophthalmic surgery


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 90
Est. completion date May 2015
Est. primary completion date January 2015
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 90 Years
Eligibility Inclusion Criteria:

- Adult patients

- Going for elective vitreoretinal surgery.

Exclusion Criteria:

- History of coagulation abnormalities.

- Allergy to local anesthetics.

- Cardiac, hepatic or renal failure,

- Chronic clonidine or analgesic therapy.

- One-eyed patients

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)


Related Conditions & MeSH terms


Intervention

Drug:
DEXMEDETOMIDINE
Does adding 5 or 10 micron of DEXMEDETOMIDINE to peribulbar anesthesia is any different from regular peribulbar anesthesia practice?

Locations

Country Name City State
Saudi Arabia King Abdulaziz University Hospital at King Saud University Riyadh

Sponsors (1)

Lead Sponsor Collaborator
King Saud University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary onset, duration of the motor and sensory block A block was considered satisfactory when complete akinesia occurred. In the absence of complete akinesia in any direction after 10 min, supplementary anesthesia given by a further injection of 2-4 ml of the test solution in the same manner as given before. Calculate the number of patients needed supplemental block were. The surgeon assessed the duration of surgery anesthesia and akinesia. Intraocular pressure measured before block, immediately after block and before surgical procedures 10 minutes from injection No
Secondary observe the adverse effects of Dexmedetomidine ECG, invasive BP and pulse oximetry will apply to all patients.
• The haemodynamic parameters (MAP and HR) will be continuously measured, and will be recorded at before induction (baseline), one minute after block . after 5 minutes then at the surgical incision, 15-min intervals intraoperatively, the end of surgery and10 and 20 minutes postoperatively.
Incidence of Oculocardiac reflex (OCR) or any arrhythmia during surgery.
during and after surgery Yes